You are here:
Publication details
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Authors | |
---|---|
Year of publication | 2016 |
Type | Article in Periodical |
Magazine / Source | Cell |
MU Faculty or unit | |
Citation | |
Doi | http://dx.doi.org/10.1016/j.cell.2016.01.015 |
Field | Oncology and hematology |
Keywords | PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; GENOMIC ANALYSIS; ABUNDANT NEUROPIL; TRUE ROSETTES; MUTATIONS; DNA; MEDULLOBLASTOMA; METHYLATION; AMPLIFICATION |
Description | Primitive neuroectodermal tumors of the central nervous system (CNS-PNETs) are highly aggressive, poorly differentiated embryonal tumors occurring predominantly in young children but also affecting adolescents and adults. Herein, we demonstrate that a significant proportion of institutionally diagnosed CNS-PNETs display molecular profiles indistinguishable from those of various other well-defined CNS tumor entities, facilitating diagnosis and appropriate therapy for patients with these tumors. From the remaining fraction of CNS-PNETs, we identify four new CNS tumor entities, each associated with a recurrent genetic alteration and distinct histopathological and clinical features. These new molecular entities, designated "CNS neuroblastoma with FOXR2 activation (CNS NB-FOXR2)," "CNS Ewing sarcoma family tumor with CIC alteration (CNS EFT-CIC)," "CNS high-grade neuroepithelial tumor with MN1 alteration (CNS HGNET-MN1)," and "CNS high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)," will enable meaningful clinical trials and the development of therapeutic strategies for patients affected by poorly differentiated CNS tumors. |